Prot#JKB-121-001: A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Phase II trial of JKB-121 for the Treatment of Nonalcoholic Steatohepatitis (NASH)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/2/159/2/18

Funding

  • Medpace, Inc. (JKB-121-001)
  • TaiwanJ Pharmaceuticals Co., Ltd. (JKB-121-001)